Table 2.
Epidemiology | Clinical characteristics | Chest imaging | Treatment | Relapse | |||||
---|---|---|---|---|---|---|---|---|---|
Onset | History of asthma | Smoking history | Blood eosinophilia | BAL eosinophilia | |||||
AEP | ~ 400* | < 1 month | No | > 75% | No | >25% | Bilateral areas of ground-glass, consolidation, interlobular septal thickening, and pleural effusion | Corticosteroids (2–4 weeks) | No |
CEP | 1–3%** | >2–4 weeks | Yes | 10% | Yes | >25% | Homogeneous peripheral consolidation | Corticosteroids (long term) anti-IgE and anti-IL5 mAb | Yes |
*Reported cases; **Interstitial lung disease; BAL, Bronchoalveolar lavage; mAb, monoclonal antibody.